NASDAQ:VIRX

Viracta Therapeutics, Inc. Stock Predictions

NASDAQ Stock Exchange > Healthcare > Biotechnology

Open Broker Account

$0.81

-0.0298 (-3.55%)

At Close: May 03, 2024

Currently predicting for Mon, 6 May 2024

Trading levels for VIRX

Fibonacci Support & Resistance Levels

		Level	Price
	Resistance	R3	0.86	5.74 %
		R2	0.84	3.86 %
		R1	0.83	2.69 %
Current price:			0.81
	Support	S1	0.80	-1.08 %
		S2	0.792	-2.24 %
		S3	0.777	-4.13 %

Accumulated Volume Support & Resistance Levels

		Level	Price
	Resistance	R3	0.99	21.57 %
		R2	0.94	15.55 %
		R1	0.85	4.95 %
Current price			0.81
	Support	S1	0.780	-3.73%
		S2	0.715	-11.77%
		S3	0.680	-16.07%

VIRX Predictions History

2 years ago
JS predicted that VIRX for 2022-04-11 is going $4.75 (33.05%)

2 years ago
kellius predicted that VIRX for 2022-04-11 is going

Rank:

About Viracta Therapeutics, Inc.

Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket trial for the treatment of various relapsed/refractory Epstein-Barr virus-positive (EBV+) lymphoma, as we... VIRX Profile

Golden Star

Ticker	Date	Change	Price
CVBF	May 01	2.75%	$16.75
FTSL	May 01	0.282%	$46.03
EQC	Apr 30	0.694%	$18.72
HRB	Apr 30	0.635%	$47.23
BSCQ	Apr 30	0.576%	$19.09
BSJP	Apr 29	0.306%	$22.91
LYG	Apr 29	1.56%	$2.56
ORA	Apr 29	4.68%	$64.48
DHT	Apr 24	3.10%	$11.28
LPLA	Apr 19	3.12%	$262.59

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In